ACTUARIAL MANAGER - CONSULTING - RE/INSURANCE - LIFE OR P&C - BERMUDA - 10% TAX - HR101 About this opportunity... as an Associate with the IFoA / SOA / CAS or equivalent 5+ years' relevant actuarial experience in consulting with either P&C or Life...
ACTUARIAL CONSULTANT - RE/INSURANCE - LIFE OR P&C - BERMUDA - 10% TAX - HR107 About this opportunity Our client... with the IFoA / SOA / CAS or equivalent institute 12-18+ months' relevant actuarial experience in consulting with either P&C...
Exciting opportunity for an ACAS/FCAS with 5+ years' Reinsurance pricing experience to lead reinsurance treaty pricing and support Bermuda-Based underwriting teams. Role involves risk management, business planning, regulatory and portfolio ...
Tunwal E-Motors IPO: With a face value of ₹2, each share in Tunwal E-Motors' initial public offering (IPO) is priced at ₹59. A minimum of 2000 shares, as well as multiples of those, are up for bid. Continue Reading »
Northern Arc Capital, which filed preliminary IPO papers with SEBI in January, received its observation letter on July 12, according to an update. Continue Reading »
A harsh summer likely aided Crompton’s June quarter results.Crompton took a strategic call to shift Butterfly’s focus from B2B to retail Continue Reading »
Sati Poly Plast IPO: The issue that opened for subscription on July 12, received a strong response as was subscribed 136.65 times by 5:00 PM on day 2. The GMP rose from ₹70 to ₹105 on day 2. The issue will be available for subscription till Tuesday 16 July 2024. Continue Reading »
IREDA's asset quality showed sequential improvement, with gross NPA reducing to 2.19% from 2.36% in March, and net NPA improving to 0.95% from 0.99% in March. Continue Reading »
Deepak Shenoy expects Nifty 50 aggregated EPS to report a high single digit on the back of strong earnings growth from sectors like Financials, Automobiles & FMCG sectors. Continue Reading »
Stock Market Today: Indian Pharma market growth at 6.7% yoy in June softened over April and May. IPCA, Glenmark, Ajanta, Mankind, Sun pharma, Zydus Lifesciences , Procter & Gamble Health Ltd, JB Pharma, Eris Lifesciences were some prominent names that with 7.2-12% yoy growth beat the IPM growth. Continue Reading »